Article Summary
Plastic surgery patient LTV is the profit a patient generates across their entire relationship with your practice — not the revenue. Most calculators stop at revenue, which is why the number they hand you is useless for running the business. The number that matters is profit-based LTV measured against what you spend to acquire a patient (LTV:CAC). The same retention that lifts that number is also what doubles your practice’s sale multiple. Here’s how to calculate it correctly.
The patient LTV number you’re using is probably wrong
If you Googled “plastic surgery patient LTV” and got the formula spend per visit × visits per year × years, you got a revenue number. That number can’t run your practice. The one that can is profit-based LTV measured against your acquisition cost.
Here’s the gap. According to AmSpa and Growth99 data cited by IAPAM, the average aesthetic patient spends about $527 per visit. Three visits a year over five years gives you a revenue LTV near $7,900. Clean number. It tells you almost nothing about whether your practice makes money, because revenue isn’t what you keep.
Out of every dollar a patient spends, how much is left after you’ve paid the people delivering the work, the room, the products, and the cost of getting that patient through the door? That leftover is the only LTV worth tracking. Bennett Financials is a fractional CFO and tax planning firm that helps service business founders doing $1M–$20M diagnose growth bottlenecks, fix margins, and build businesses worth selling — and the first thing I do with a practice owner’s LTV number is strip it down to profit. I run a fractional CFO practice built around exactly this kind of diagnostic.
Picture a single-location practice doing about $2M in revenue — the average, per Ankura’s analysis of the medspa sector. The owner thinks each patient is worth $7,900. After margin and acquisition cost, the real figure might be a third of that. That’s the gap between a number that looks good on a slide and a number you can make decisions with.
How to actually calculate plastic surgery patient LTV
The three inputs
Patient LTV starts with three things: average spend per visit, visits per year, and years retained. Multiply them and you get gross revenue LTV. A patient spending $527 a visit, coming three times a year, staying five years, is worth roughly $7,900 in revenue. That’s the number every calculator gives you. It’s step one, not the answer.
The profit strip — why revenue LTV lies
Now strip it to profit. Revenue LTV ignores that delivering the work costs money. Zenoti puts net margins for high-performing aesthetic practices at 20% to 25%, and margins swing hard by procedure — injectables can run 50–70% gross margin, while surgical cases carry far heavier delivery labor.
So take that $7,900 revenue LTV. At a 25% net margin, the patient is worth about $1,975 in profit. At 20%, $1,580. That’s the range you actually plan against — somewhere between $1,580 and $1,975, not $7,900. If you’ve been budgeting acquisition spend against the revenue number, you’ve been overpaying for patients and calling it growth. The plastic surgery practices I work with almost always start with the revenue figure and get a jolt when we run the profit version.
The surgical-vs-injectable split most calculators miss
Here’s what blending does to your number: it hides which side of the practice is actually compounding.
One-time surgical LTV vs recurring injectable LTV
A rhinoplasty or a breast augmentation is, for most patients, a one-time event. High ticket, big margin hit from surgical labor, and then the patient may never book a major procedure again. That’s a one-time LTV.
Injectables, lasers, skincare, and memberships are the opposite — lower ticket, higher margin, and recurring. Prospyr reports that repeat clients can account for up to 65% of revenue and spend 67% more than first-timers. That’s where lifetime value compounds.
Why blending them hides your real number
If you average a one-time $12,000 surgical case with a recurring $400-a-quarter injectable patient, you get a blended LTV that describes neither. You can’t tell whether your growth engine is the surgical side (which resets to zero after every case and depends on constant new-patient flow) or the recurring side (which builds on itself). Calculate them separately. The recurring base is also what makes the practice predictable enough to be worth more — and predictable recurring revenue is the kind of structure a proactive tax strategy can actually plan around, instead of reacting to a lumpy surgical year.
LTV:CAC — the gate that tells you if your number is any good
A profit LTV on its own still doesn’t tell you if it’s healthy. You need the gate: LTV:CAC of at least 4:1, with acquisition cost paid back inside 6 months.
Four to one because below that the math stops working. At 2:1 you’re spending fifty cents to make a dollar — there’s no room left for overhead, and you’re one ad-cost increase from losing money on every patient. At 4:1 the patient covers acquisition, delivery, and overhead with margin left to reinvest. That’s the band where growth funds itself instead of draining the bank account.
Run the example. If your profit LTV is $1,975 and you’re spending $500 to acquire a patient, that’s a 3.95:1 ratio — right at the line. If acquisition creeps to $700, you’ve dropped to 2.8:1 and you’re underwater on overhead. This is why retention matters more than most owners think. Prospyr’s data shows top-performing clinics retain 60–70% of clients, and a 5% lift in retention can raise profit by 25% to 95%. Hold the patient one more year and LTV climbs while CAC stays flat — the ratio fixes itself without spending another dollar on ads.
What most practices get wrong: chasing new patients
Most practices answer a weak LTV:CAC ratio by buying more patients. That’s the mistake. More acquisition spend against a leaky practice just raises CAC and drops the ratio further.
Think of it like this: a patient you keep costs nothing to re-acquire, and they spend more each year. A patient you replace costs you the full CAC again. When the ratio is broken, the fix lives in retention and pricing — not the ad budget. The diagnostic order matters here, and it’s the opposite of what most practices run. Fix the profit per patient and the retention first; the acquisition math takes care of itself once the patient is actually worth keeping. Buying volume on top of broken unit economics just scales the leak.
I’ve never once fixed a practice’s growth problem by spending more on ads first. The number that moves everything is what a patient is worth after you keep them — get that right and the marketing starts working on its own.
Want to know where your business sits against the 60-15-15 standard? The Scale-Ready Assessment runs your actual numbers, builds a custom tax strategy, and produces a full enterprise value report. Free for US-based service businesses doing $1M–$20M. Book your free Assessment — 15 spots per month.
The valuation payoff: your LTV is also your sale multiple
Here’s the part no LTV calculator tells you. The same retention that lifts your patient LTV is the single biggest lever on what your practice sells for.
Plastic surgery already commands strong multiples — First Page Sage’s 2025 data puts practices in the $1M–$3M EBITDA band at roughly 7.3x EBITDA, the highest of any healthcare subsector. But that’s the headline number, not your number. Two practices with identical revenue can sell for completely different prices, and the difference is risk.
A practice that runs on one surgeon’s calendar is what buyers call key-man risk — when the owner is the product, the business is a job, not an asset, and it sells at a discount. A practice with a recurring injectable base, associate providers, and predictable revenue gets the premium. Aesthetic revenue alone can add one to two turns to the multiple. That recurring LTV you calculated separately a few sections ago? It’s not just a margin story — it’s a valuation story. Building a practice that runs without you isn’t “exit planning,” it’s operational maturity, and it gives you the choice to sell at a premium or keep it running independently. That’s the work behind building a business worth selling — and the full scoring behind the multiple is something I walk owners through directly, because it’s more than a single ratio.
How a healthcare practice fixed this: NuSpine
NuSpine is a chiropractic practice — a recurring-visit healthcare business, same shape as the injectable side of an aesthetic practice. The owner was growing on gut feel. The bookkeeping told him what happened last month but gave him no direction, no roadmap, no sense of what a patient was actually worth or where the business was heading.
I came in as strategic CFO support: clear goals, real benchmarks, and a long-term wealth roadmap with milestones and timelines instead of month-to-month guessing. The friction was real at the start — the owner was skeptical that financial strategy, as opposed to just cleaner bookkeeping, would change anything. He’d had a bookkeeper. Why would a CFO be different?
The difference showed up in the outcomes. The financial clarity let him execute a clean exit from his previous business, and that exit capital funded chiropractic franchise acquisitions — he moved from operator to owner-investor. As he put it, the wealth came from having a long-term plan with milestones and timeframes, not random financial moves. The number on the page mattered less than knowing which number to chase.
Book a free Scale-Ready Assessment — three deliverables: full 60-15-15 financial diagnostic, a tax plan, and an enterprise value report showing your current multiple and the gap. 15 spots per month.
